These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The controversy over Guidant's implantable defibrillators. Steinbrook R N Engl J Med; 2005 Jul; 353(3):221-4. PubMed ID: 16034006 [No Abstract] [Full Text] [Related]
4. The Food and Drug Administration and atrial defibrillation devices. Chen L; Keane AT; Every NR Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410 [TBL] [Abstract][Full Text] [Related]
5. Microvolt T-wave alternans testing to risk stratify patients being considered for ICD therapy for primary prevention of sudden death. Blue Cross Blue Shield Association Technology Evaluation Center Technol Eval Cent Assess Program Exec Summ; 2007 May; 21(14):1-3. PubMed ID: 17557413 [No Abstract] [Full Text] [Related]
6. Microvolt T-wave alternans testing to risk stratify patients being considered for ICD therapy for primary prevention of sudden death. Technol Eval Cent Assess Program Exec Summ; 2005 Oct; 20(9):1-3. PubMed ID: 16267944 [No Abstract] [Full Text] [Related]
7. Medical-device safety and the FDA. Schultz DG N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278 [No Abstract] [Full Text] [Related]
9. Semper fidelis--consumer protection for patients with implanted medical devices. Maisel WH N Engl J Med; 2008 Mar; 358(10):985-7. PubMed ID: 18322280 [No Abstract] [Full Text] [Related]
10. Cost and effectiveness: approval and payment for Pulverizer. Riegelman R Md Med; 2002; 3(3):50-4. PubMed ID: 12214498 [No Abstract] [Full Text] [Related]
11. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework? Basile EM; Lorell BH Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031 [No Abstract] [Full Text] [Related]
12. Medical device technology user fees. Bailey PG Med Device Technol; 2002 Sep; 13(7):37-8. PubMed ID: 12397834 [TBL] [Abstract][Full Text] [Related]
13. New type of defibrillator. FDA Consum; 2002; 36(4):7. PubMed ID: 12184312 [No Abstract] [Full Text] [Related]
15. FDA's device inspection lacking. Two reports point to technology, staffing as key culprits. Rhea S Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18318369 [No Abstract] [Full Text] [Related]
16. You have a friend at the FDA. Schoem SR Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1358. PubMed ID: 14676182 [No Abstract] [Full Text] [Related]
17. Missing evidence. Hayes WS MLO Med Lab Obs; 2008 Oct; 40(10):68. PubMed ID: 18988559 [No Abstract] [Full Text] [Related]
18. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective. Sapirstein W Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379 [No Abstract] [Full Text] [Related]
19. Stent thrombosis redux--the FDA perspective. Farb A; Boam AB N Engl J Med; 2007 Mar; 356(10):984-7. PubMed ID: 17296827 [No Abstract] [Full Text] [Related]
20. [Standards for manufacturing implantable breast prostheses]. Petoin S Ann Chir Plast Esthet; 1994 Dec; 38(6):680-6. PubMed ID: 7847715 [No Abstract] [Full Text] [Related] [Next] [New Search]